CANDOUR logo

Brief Description of Research

An effective vaccine will help end the COVID-19 pandemic. Clinical trials for the COVID-19 vaccine are very promising. While enormous research effort and resources have been put into vaccine development, there is currently no evidence-based framework for the allocation of a vaccine to both maximise outcomes and ensure an equitable distribution. Current trials indicate that a vaccine offering protection against COVID-19 is immanent and will receive regulatory approval very soon. Governments will have to make immediate decisions on how to allocate available supplies. In many countries, these will not be sufficient for universal vaccination, and so choices will need to be made as to which groups are prioritised to receive a vaccine.

It will be essential both ethically and politically that the vaccine allocation receives public input on which different types of needs should be prioritised (e.g. essential workers versus those at highest risk of dying of COVID-19). The CANDOUR project is conducting national representative surveys in twelve countries in anticipation of trial results being finalized in the coming months. It will be used to help develop a fair and efficient allocation mechanism to facilitate vaccine prioritization.

The team of scholars participating in this global project, and described in the Team tab, have stellar international reputations for the design and implementation of studies concerning public health attitudes and behaviour. They also have been on the forefront of theoretical modelling and econometric estimation methods that will be essential for the success of this project.

The CANDOUR study was supported by a National Institute for Health Research Biomedical Research Centre at the University of Oxford (grant number NIHR-BRC-1215-20008) and a grant from EuroQol Research Foundation.

The Project Team

The Principal Investigator on The Oxford COVID-19 Vaccine Policy project is Professor Philip Clarke. The current team of scholars collaborating on the project include the following:

Professor Philip Clarke
Professor Philip Clarke
Director

Health Economics Research Centre

Nuffield Department of Population Health

Mariana Blanco
Mariana Blanco

Facultad de Economia

Universidad del Rosario

Bogota

Jean-Francois Bonnefon
Jean-Francois Bonnefon

Toulouse School of Economics

Toulouse

John Buckell
John Buckell

Nuffield Department of Population Health

Ray Duch
Ray Duch

Nuffield College

University of Oxford

Jorge Friedman
Jorge Friedman
Dean

Faculty of Administration and Economics

University of Santiago Chile

Juan Vargas
Juan Vargas

Facultad de Economia

Universidad del Rosario

Bogota

Peter Loewen
Peter Loewen

Munk School of Global Affairs & Public Policy

University of Toronto

Alessia Melegaro
Alessia Melegaro

University of Bocconi

Milan

Pavan Mamidi
Pavan Mamidi
Dean

Center for Social and Behavioral Change

New Delhi, Delhi, India

Laurence Roope
Laurence Roope

Nuffield Department of Population Health

University of Oxford

Mara Violato
Mara Violato

Nuffield Department of Population Health

University of Oxford